Viking Therapeutics plans USD 200 million convertible senior notes offering due 2032
Bitget2026/09/23 20:33- Viking Therapeutics launched a public offering of USD 200 million convertible senior notes due 2032.
- Underwriters hold a 30-day option to buy up to an additional USD 30 million of the notes for over-allotments.
- Notes to mature Oct. 15, 2032; senior unsecured; interest payable semi-annually; conversion settled in cash, shares, or both.
- Redemption allowed from Oct. 22, 2029 if shares trade above 130% of the conversion price for a specified period.
- Proceeds earmarked for development and commercialization of VK2735, advancement of VK3019, working capital, and general corporate purposes.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Analysis: Wall Street Is Not Yet Ready to Short AI in Large Numbers
Overseas capital is aggressively buying US stocks! Net inflows reached $942 billions over the past 12 months, marking a record since 1985.
According to data from the US Department of the Treasury, in the 12 months ending July this year, overseas investors made net purchases of US stocks totaling $942 billion, marking the highest rolling 12-month total since records began in 1985. The net purchases in the second quarter alone reached $426 billion, setting a new single-quarter record. Meanwhile, overseas demand for US Treasuries has noticeably cooled, with purchase volumes falling significantly. As a result, the US is facing higher costs in government debt financing.
RootData: BIO will unlock tokens worth about $1 million in one week
Crypto prices
More
